Cullinan Therapeutics, Inc. (CGEM)
21.55
-0.52
(-2.36%)
USD |
NASDAQ |
Sep 01, 09:58
Cullinan Therapeutics Cash from Operations (Annual) : -175.75M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -175.75M |
| December 31, 2024 | -145.30M |
| December 31, 2023 | -134.28M |
| December 31, 2022 | -126.66M |
| Date | Value |
|---|---|
| December 31, 2021 | -43.43M |
| December 31, 2020 | -29.77M |
| December 31, 2019 | -20.90M |
| December 31, 2018 | -13.55M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Rallybio Corp. | -29.81M |
| MapLight Therapeutics, Inc. | -138.14M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |
| Sangamo Therapeutics, Inc. | -97.21M |